Study of KN026 Monotherapy or Combination Therapy in Patients With Metastatic Breast Cancer
Clinical trial NCT04165993 · UNKNOWN
Trial details
- NCT number
- NCT04165993
- Sponsor
- Jiangsu Alphamab Biopharmaceuticals Co., Ltd
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-12-31
- Primary completion
- 2021-05-27
- Enrollment
- 68
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.